Stay updated on BI 655130 Dosing in Palmoplantar Pustulosis Clinical Trial

Sign up to get notified when there's something new on the BI 655130 Dosing in Palmoplantar Pustulosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the BI 655130 Dosing in Palmoplantar Pustulosis Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision label updated to v3.4.3, replacing the previous v3.4.2 label.
    Difference
    0.0%
    Check dated 2026-03-06T18:11:26.000Z thumbnail image
  3. Check
    18 days ago
    No Change Detected
  4. Check
    25 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2.
    Difference
    0.0%
    Check dated 2026-02-20T10:10:00.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.4.1, replacing v3.4.0, indicating a minor update to the page content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T23:49:33.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    Added the label 'Last Update Posted' to the Study Record Dates and removed 'Last Update Posted (Estimated)'. This clarifies when the study record was last updated and eliminates the estimated tag.
    Difference
    0.0%
    Check dated 2026-01-22T09:58:04.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    Revision: v3.3.4 added; Revision: v3.3.3 removed.
    Difference
    0.0%
    Check dated 2026-01-15T10:32:35.000Z thumbnail image
  8. Check
    89 days ago
    Change Detected
    Summary
    The study locations section was expanded to show detailed site listings across multiple US states (Alabama, California, Georgia, Kansas, Missouri, Nebraska, New Jersey, Pennsylvania, Texas, Utah, Virginia) and international regions (Australia: ACT, NSW, Queensland, Victoria; Canada: Alberta, New Brunswick, Ontario, Quebec). The page also removed the HHS Vulnerability Disclosure link and updated to revision v3.3.3.
    Difference
    1%
    Check dated 2025-12-17T19:53:05.000Z thumbnail image

Stay in the know with updates to BI 655130 Dosing in Palmoplantar Pustulosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the BI 655130 Dosing in Palmoplantar Pustulosis Clinical Trial page.